Allergan Inc (AGN)

AGN (NYSE:Drugs)
$179.25
pos +1.76
+0.99%
Today's Range: 178.69 - 181.66 | AGN Avg Daily Volume: 2,304,600
Last Update: 10/20/14 - 4:00 PM EDT
Volume: 2,094,319
YTD Performance: 59.79%
Open: $180.01
Previous Close: $177.49
52 Week Range: $88.34 - $192.98
Oustanding Shares: 297,183,809
Market Cap: 52,898,718,002
6-Month Chart
TheStreet Ratings Grade for AGN
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 9 6 7 5
Moderate Buy 0 0 0 0
Hold 4 6 5 7
Moderate Sell 0 0 0 0
Strong Sell 1 1 1 1
Mean Rec. 1.86 2.23 2.08 2.38
Latest Dividend: 0.05
Latest Dividend Yield: 0.12%
Dividend Ex-Date: 08/13/14
Price Earnings Ratio: 38.66
Price Earnings Comparisons:
AGN Sector Avg. S&P 500
38.66 42.20 26.85
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
7.04% 95.71% 110.87%
GROWTH 12 Mo 3 Yr CAGR
Revenue 8.50 0.28 0.09
Net Income -10.30 258.69 5.26
EPS -9.80 0.00 0.00
Earnings for AGN:
EBITDA 2.07B
Revenue 6.30B
Average Earnings Estimates
Qtr (09/14) Qtr (12/14) FY (12/14) FY (12/15)
Average Estimate $1.76 $1.71 $6.24 $8.56
Number of Analysts 5 10 6 6
High Estimate $1.78 $1.83 $6.26 $8.60
Low Estimate $1.74 $1.53 $6.23 $8.44
Prior Year $1.23 $1.35 $4.77 $6.24
Growth Rate (Year over Year) 43.09% 26.67% 30.89% 37.19%
Chart Benchmark Timeframe
Average Frequency Indicator Chart
Scale Symbol Comparison Bollinger Bands
By

Kate Stalter

 | Oct 17, 2014 | 1:00 PM EDT

Hospitals, biotechs and drug makers continue to hold their own.

By

Kate Stalter

 | Oct 17, 2014 | 1:00 PM EDT

Hospitals, biotechs and drug makers are continuing to hold their own during this downturn.

By

Jim Cramer

 | Oct 9, 2014 | 4:08 PM EDT

Stop picking on PepsiCo, Allergan and Apple.

bullishAllergan rated new Buy at Deutsche

Oct 9, 2014 | 8:18 AM EDT

AGN was initiated with a Buy rating, Deutsche Bank said. $215 price target. Company has strong finances and an attractive pipeline that can fund organic growth. 

By

Bob Byrne

 | Oct 8, 2014 | 7:30 AM EDT

The miners are untouchable.

bullishAllergan upgraded at Stifel

Oct 1, 2014 | 8:12 AM EDT

AGN was upgraded from Hold to Buy, Stifel Nicolaus said. $200 price target. Company has several options to generate better shareholder returns.

 

By

Jim Cramer

 | Sep 23, 2014 | 11:47 AM EDT

Be picky in this tough market.

By

Jim Cramer

 | Sep 8, 2014 | 12:30 PM EDT

Sadly, these five themes have driven folks away from the market's remarkable five-year run.

By

Jim Cramer

 | Aug 12, 2014 | 11:42 AM EDT

TheStreet's Jim Cramer says Valeant's bid to acquire Allergan may have hit a 'high water mark.'

bullishAllergan upgraded at Leerink

Aug 8, 2014 | 7:40 AM EDT

AGN was upgraded from Market Perform to Outperform, Leerink Swann said. Risk/reward is compelling, following a significant pullback in the stock. $184 price target. 

FB has earnings due out on 10-28-2014, after the market closes. I will write a full earni...
Solid opening day to trading week for a change as indices across the board as even the DJI...
Apple reports after the close today. St expecting Q4 rev of $39.877 billion, up 6.4%. EPS ...
The squeezing high we has been looking for, turned out to surpass our wildest expectations...

REAL MONEY PRO'S BEST IDEAS

Columnist Tweets

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.